Back to search

Article

Mitochondrial ROS drive resistance to chemotherapy and immune killing in hypoxic non-small cell lung cancer

2022-05-27

Abstract excerpt

<title>Abstract</title> <p>Background. Solid tumors subjected to intermittent hypoxia are characterized by resistance to chemotherapy and immune-killing by effector T-lymphocytes, particularly tumor-infiltrating Vγ9Vδ2 T-lymphocytes. The molecular circuitries determining this double resistance are not known. Methods. We analyzed a panel of 28 human non-small cell lung cancer (NSCLC) lines, using an <italic>in v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8b4a33fc-dc73-5794-9ab3-814060d253d0
DOI
10.21203/rs.3.rs-1684602/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mitochondrial ROS drive resistance to chemotherapy and immune killing in hypoxic non-small cell lung cancerDOI 10.21203/rs.3.rs-1684602/v1
Select a neighboring publication to make it the new centre.